Extension of stability studies of metarrestin (ML246), period of performance 1/28/2021 - 3/31/2021.

Ended Awarded Last action

Contract number
75N95021F00001
Awardee
Awarding agency
Obligated
$32,600

Award facts

Opportunity
  • 75N95021R00015 Solicitation number
Contract value 100% obligated
$32,600.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75N95021F00001?

75N95021F00001 was awarded to Societal Cdmo San Diego, LLC by National Institute on Drug Abuse (National Institutes of Health) on May 25, 2020.

How much is contract 75N95021F00001 worth?

The government has obligated $32,600 on 75N95021F00001.

Which agency awarded contract 75N95021F00001?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95021F00001 an order under another contract?

Yes. 75N95021F00001 is a delivery order under HHSN271201700020I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.

Was contract 75N95021F00001 competed?

The extent of competition for 75N95021F00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award